InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by West Thomas A., Chairman & CEO. Director active across 2 companies, notably Intersect ENT, Inc.. Aggregated, 6 disclosures have been logged. The latest transaction was disclosed on 6 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
06,383 shares0
Common Stock
SEC:0001209191-22-035043:0·
€1m39,700 shares@ €27.216962.6% of flow
Common Stock
SEC:0001562180-22-004071:0·
0106,540 shares0
Common Stock
SEC:0001562180-22-001158·
0106,540 shares0
Common Stock
SEC:0001562180-22-001158:0·
€322,71719,243 shares@ €16.7706100.0% of flow
Common Stock
SEC:0001562180-21-005070·
€322,71719,243 shares@ €16.770618.7% of flow
Common Stock
SEC:0001562180-21-005070:0·
6 of 6 declarations
About West Thomas A.
Thomas A. West is President and Chief Executive Officer of Intersect ENT, Inc. and Orthofix Medical Inc. In these roles, he is responsible for the strategic and operational leadership of both companies. West implements initiatives aimed at driving growth and enhancing profitability. His leadership and vision are essential for achieving the long-term goals of Intersect ENT and Orthofix.
